These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21892695)

  • 1. Nitrendipine nanocrystals: its preparation, characterization, and in vitro-in vivo evaluation.
    Quan P; Xia D; Piao H; Piao H; Shi K; Jia Y; Cui F
    AAPS PharmSciTech; 2011 Dec; 12(4):1136-43. PubMed ID: 21892695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability.
    Xia D; Quan P; Piao H; Piao H; Sun S; Yin Y; Cui F
    Eur J Pharm Sci; 2010 Jul; 40(4):325-34. PubMed ID: 20417274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel surface modified nitrendipine nanocrystals with enhancement of bioavailability and stability.
    Quan P; Shi K; Piao H; Piao H; Liang N; Xia D; Cui F
    Int J Pharm; 2012 Jul; 430(1-2):366-71. PubMed ID: 22531846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of crystal size on the in vitro dissolution and oral absorption of nitrendipine in rats.
    Xia D; Cui F; Piao H; Cun D; Piao H; Jiang Y; Ouyang M; Quan P
    Pharm Res; 2010 Sep; 27(9):1965-76. PubMed ID: 20585842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics.
    Kumar VV; Chandrasekar D; Ramakrishna S; Kishan V; Rao YM; Diwan PV
    Int J Pharm; 2007 Apr; 335(1-2):167-175. PubMed ID: 17161566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Oral Bioavailability of Lacidipine Using Nanosuspension Technology: Inferior in vitro Dissolution and Superior in vivo Drug Absorption versus Lacipil®.
    Zhao J; Luo L; Fu Q; Guo B; Li Y; Geng Y; Wang J; Zhang T
    Curr Drug Deliv; 2016; 13(5):764-73. PubMed ID: 25963306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of dissolution and bioavailability of nitrendipine by inclusion in hydroxypropyl-beta-cyclodextrin.
    Choi HG; Kim DD; Jun HW; Yoo BK; Yong CS
    Drug Dev Ind Pharm; 2003 Nov; 29(10):1085-94. PubMed ID: 14677769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solvent-mediated amorphous-to-crystalline transformation of nitrendipine in amorphous particle suspensions containing polymers.
    Xia D; Wu JX; Cui F; Qu H; Rades T; Rantanen J; Yang M
    Eur J Pharm Sci; 2012 Aug; 46(5):446-54. PubMed ID: 22484330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
    Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
    Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration.
    Manjunath K; Venkateswarlu V
    J Drug Target; 2006 Nov; 14(9):632-45. PubMed ID: 17090399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation of nimodipine nanocrystals for oral administration.
    Li J; Fu Q; Liu X; Li M; Wang Y
    Arch Pharm Res; 2016 Feb; 39(2):202-212. PubMed ID: 26584914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of the dissolution rate of nitrendipine using a new pulse combustion drying method.
    Wang L; Cui FD; Sunada H
    Chem Pharm Bull (Tokyo); 2007 Aug; 55(8):1119-25. PubMed ID: 17666831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymer-mediated anti-solvent crystallization of nitrendipine: monodispersed spherical crystals and growth mechanism.
    Xia D; Ouyang M; Wu JX; Jiang Y; Piao H; Sun S; Zheng L; Rantanen J; Cui F; Yang M
    Pharm Res; 2012 Jan; 29(1):158-69. PubMed ID: 21748536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different methods for preparation of a stable riccardin D formulation via nano-technology.
    Liu G; Zhang D; Jiao Y; Zheng D; Liu Y; Duan C; Jia L; Zhang Q; Lou H
    Int J Pharm; 2012 Jan; 422(1-2):516-22. PubMed ID: 22119965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of SLN and NLC enriched hydrogels for transdermal delivery of nitrendipine: in vitro and in vivo characteristics.
    Bhaskar K; Krishna Mohan C; Lingam M; Jagan Mohan S; Venkateswarlu V; Madhusudan Rao Y; Bhaskar K; Anbu J; Ravichandran V
    Drug Dev Ind Pharm; 2009 Jan; 35(1):98-113. PubMed ID: 18665979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of nitrendipine transdermal patches: in vitro and ex vivo characterization.
    Gannu R; Vishnu YV; Kishan V; Rao YM
    Curr Drug Deliv; 2007 Jan; 4(1):69-76. PubMed ID: 17269919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Nanonized Nitrendipine and Its Transformation into Nanoparticulate Oral Fast Dissolving Drug Delivery System.
    Gandhi NV; Deokate UA; Angadi SS
    AAPS PharmSciTech; 2021 Mar; 22(3):113. PubMed ID: 33751276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of nitrendipine solid lipid nanoparticles.
    Manjunath K; Venkateswarlu V; Hussain A
    Pharmazie; 2011 Mar; 66(3):178-86. PubMed ID: 21553647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and evaluation of solid dispersions of nitrendipine prepared with fine silica particles using the melt-mixing method.
    Wang L; Cui FD; Sunada H
    Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):37-43. PubMed ID: 16394546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.